基因分型市场战略、顶尖企业、增长机会、2031 年分析及预测

  • Report Code : TIPHE100001166
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 250
Buy Now

Genotyping Market Growth Drivers and Opportunities by 2031

Buy Now

基因分型市场规模预计将从 2023 年的 304.4 亿美元增至 2031 年的 1543.5 亿美元。预计 2023-2031 年期间,该市场的复合年增长率将达到 22.5%。由于不断增强的宣传力度和活动,基因分型的应用范围十分广泛,包括个性化医疗、农业和动物育种,这将继续成为市场的主要趋势。

基因分型市场分析

新一代测序和微阵列分析等高通量基因分型技术的发展使基因分型市场受益。随后,基因分型在农业和动物育种中的应用越来越广泛,以提高作物产量、开发抗病作物和提高畜牧业产量,这是基因分型市场增长的主要驱动力之一。基因组学、遗传学和相关领域的持续研发活动,导致发现新的遗传标记和与疾病的关联,也促进了市场的发展。

基因分型市场概览

印度人口众多、出生率高,且部分社区偏好近亲结婚,因此遗传性疾病的发病率相对较高。印度正在开展人类遗传学、基因组分析和精准医疗方面的研发工作,希望通过了解疾病的突变谱来减轻此类疾病的负担。这些研发项目侧重于实施产前和新生儿筛查计划、开发具有成本效益的遗传疾病诊断方法和负担得起的此类疾病治疗方法,以及创建个性化医疗方案。

癌症等遗传性疾病在印度很普遍。根据世界卫生组织的数据,2022 年印度约有 141 万人患有癌症。题为“国家癌症登记计划下印度 11 个地理区域的乳腺癌生存率”的文章将乳腺癌列为该国最常见的癌症,因为它占女性所有癌症病例的约 28.2%;2022 年报告的女性乳腺癌病例约 216,108 例。

印度基因组研究的主要项目和举措如下:

  • DBT – 治疗遗传性疾病的独特方法 (UMMID) 计划
  • 印度基因组
  • 印度部分内婚人群的人体微生物组计划
  • 单基因遗传病项目
  • 国家基因组学核心

因此,基因组研究项目和计划的激增将为未来几年印度基因分型市场的增长提供重大机遇。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

基因分型市场:

基因分型市场
  • Genotyping Market
    复合年增长率(2023 - 2031)
    22.5%
  • 2023 年市场规模
    304.4 亿美元
  • 2031年市场规模
    1543.5亿美元

市场动态

增长动力
  • 用于诊断遗传病和罕见病
未来趋势
  • 个性化医疗日益普及
机会
  • 扩大应用范围

关键人物

  • F. 霍夫曼-罗氏有限公司
  • 凯杰公司
  • 默克公司
  • Eurofins Genomics
  • 赛默飞世尔科技公司
  • BioTek 仪器公司
  • 西尔里斯
  • Trimgen 公司
  • 照明公司
  • 丹纳赫公司

区域概况

Genotyping Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Genotyping Market产品类型
  • 仪器
  • 试剂和试剂盒
  • 生物信息学
  • 基因分型服务
Genotyping Market技术
  • 微阵列
  • 毛细管电泳
  • 测序
  • 聚合酶链式反应
  • 基质辅助激光解吸/MALDI-TOF
  • 其他技术
Genotyping Market应用
  • 药物基因组学
  • 诊断和个性化医疗
  • 动物遗传学
  • 农业生物技术
  • 其他应用
Genotyping Market最终用户
  • 制药和生物制药公司
  • 诊断和研究实验室
  • 学术机构
  • 其他最终用户
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

基因分型市场驱动因素和机遇

用于诊断遗传和罕见疾病的市场前景看好

根据世界卫生组织 (WHO) 的数据,到 2050 年可能会出现约 3500 万例新发癌症病例,比 2022 年的 2000 万例增加 77%。2022 年,阿尔茨海默病协会表示,美国患有阿尔茨海默病的人数正在迅速增加。这种疾病影响了所有年龄段的 600 多万美国人。据该协会估计,截至 2022 年,650 万 65 岁以上的美国人患有阿尔茨海默病,其中 73% 的人年龄在 75 岁或以上。根据《健康监测杂志》发表的一项研究,全球有多达 3 亿人患有罕见疾病。虽然单个疾病很少见,但它们共同对全球医疗保健系统构成了重大挑战。

由于癌症、阿尔茨海默病和罕见病在临床上难以识别,因此基因分型成为人群诊断检测的支柱。可将从基因分型中获得的 DNA 序列与样本或参考序列进行比较以确定变异。基因分型还用于检测单核苷酸多态性 (SNP),即人群中遗传补体的微小变异。人类基因组有近 6.6 亿个 SNP,这使它们成为最普遍的遗传变异。此外,通过比较健康和患病人群的多态性,全基因组关联研究 (GWAS) 可以发现常见疾病与 SNP 之间的联系。GWAS 可以通过寻找可能的原因来解开潜在疾病状态的分子机制。SNP 甚至存在于单细胞生物中,例如细菌。SNP 基因分型可以区分微生物分离物,甚至可以用于识别抗生素耐药菌株。基于SNP的菌株检测对各个药物和临床分析都有着重大的影响,并且在传染病流行病学中也得到了应用。

因此,基因分型技术在遗传疾病和罕见疾病诊断中的应用促进了基因分型市场的发展。

扩大应用范围为市场提供机会

基因分型在诊断研究、药物基因组学和农业生物技术方面具有潜在的应用前景。此外,该技术适用于各种植物育种、法医和环境检测程序。制药公司正从多基因风险评分、与患者健康信息相关的大量基因数据库以及临床试验参与者的测序数据等进步中获益。制药公司协会行业药物基因组学工作组 (I-PWG) 积极参与药物基因组学研究。I-PWG 由 26 家成员公司组成,每年进行大量临床试验,收集研究对象的 DNA 样本作为协议的一部分。I-PWG 专注于临床药物基因组学,旨在为制药公司在未来几年创造机会。除了在肿瘤学研究中最常见的用途外,临床药物基因组学还用于在罕见疾病、免疫学和心脏病学等非肿瘤治疗领域进行的 PGx 研究。涉及临床试验样本 NGS 的更全面研究可以对试验参与者进行详尽的基因组评估,揭示常见和罕见的遗传变异。PGx 包括研究基因组水平药物/外来生物效应、药物反应和疾病易感性以及基因型/表型关系的多态性差异。因此,在各个研究领域更广泛地采用基因分型最终将导致对这些技术的需求增加,从而在未来几年为市场创造巨大的机会。

基因分型市场报告细分分析

有助于得出基因分型市场分析的关键部分是产品类型、技术、应用和最终用户。

  • 根据产品类型,基因分型市场分为仪器、试剂和试剂盒、生物信息学和基因分型服务。试剂和试剂盒部分在 2023 年占据了最大的市场份额。
  • 根据技术,基因分型市场分为微阵列、毛细管电泳、测序、基质辅助激光解吸/电离飞行时间 (MALDI-ToF) 质谱、聚合酶链反应 (PCR) 等。PCR 细分市场在 2023 年占据最大市场份额。
  • 根据应用,基因分型市场细分为药物基因组学、诊断和个性化医疗、动物遗传学、农业生物技术等。诊断和个性化医疗领域在 2023 年占据了最大的市场份额。
  • 根据最终用户,基因分型市场分为制药和生物制药公司、诊断和研究实验室、学术机构等。制药和生物制药公司部门在 2023 年占据了最大的市场份额。

基因分型市场份额按地区分析

基因分型市场报告的地理范围主要分为五个区域:北美、亚太、欧洲和中东及非洲。2023 年,北美占据了市场主导地位。越来越多地采用技术先进的产品和解决方案,以及不断涌现的研发活动是该地区基因分型市场受益的因素。此外,政府主导的计划(例如“我们所有人的研究计划”)、各种基因组学社区的举措以及对基因分型服务的日益认识推动了整个北美市场的扩张。预计亚太地区在预测期内的复合年增长率最高。

基因分型市场报告范围

报告属性细节
2023 年的市场规模304.4亿美元
2031 年市场规模1543.5亿美元
全球复合年增长率(2023 - 2031)22.5%
史料2021-2022
预测期2024-2031
涵盖的领域按产品类型
  • 仪器
  • 试剂和试剂盒
  • 生物信息学
  • 基因分型服务
按技术分类
  • 微阵列
  • 毛细管电泳
  • 测序
  • 聚合酶链式反应
  • 基质辅助激光解吸/MALDI-TOF
  • 其他技术
按应用
  • 药物基因组学
  • 诊断和个性化医疗
  • 动物遗传学
  • 农业生物技术
  • 其他应用
按最终用户
  • 制药和生物制药公司
  • 诊断和研究实验室
  • 学术机构
  • 其他最终用户
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • F. 霍夫曼-罗氏有限公司
  • 凯杰公司
  • 默克公司
  • Eurofins Genomics
  • 赛默飞世尔科技公司
  • BioTek 仪器公司
  • 西尔里斯
  • Trimgen 公司
  • 照明公司
  • 丹纳赫公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

基因分型市场新闻和最新发展

基因分型市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了市场中的一些发展情况:

  • Standard BioTools Inc. 在 X9 高通量基因组学系统上推出了 NGS 文库制备功能。通过此次发布,客户现在可以首次在单个台式系统上执行实时 PCR 和下一代测序 (NGS) 文库制备应用,以支持通过筛选进行发现。(来源:Standard BioTools Inc.,公司网站,2023 年 5 月)
  • Bio-Rad Laboratories, Inc. 推出了 PTC Tempo 48/48 和 PTC Tempo 384 热循环仪,旨在支持基础和转化研究、工艺开发和质量控制中的 PCR 应用。PTC Tempo 48/48 和 PTC Tempo 384 热循环仪是 Bio-Rad 传统 PCR 热循环仪产品组合的最新成员。(来源:Bio-Rad Laboratories, Inc.,公司网站,2022 年 9 月)

基因分型市场报告覆盖范围和交付成果

“基因分型市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内涵盖的所有主要细分市场的全球、区域和国家/地区基因分型市场规模和预测
  • 基因分型市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 基因分型市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及基因分型市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the future trends of the genotyping market?

The increasing popularity of personalized medicine would persist as a prime trend in the market in the coming years.

Which region dominated the genotyping market in 2023?

North America dominated the market in 2023.

What are the driving factors impacting the genotyping market?

The use in the diagnosis of genetic and rare diseases, and technological advancements and rising R&D investments in the biotechnology and pharmaceutical industry are among the most significant factors fueling the market growth.

What would be the estimated value of the genotyping market by 2031?

The genotyping market value is expected to reach US$ 154.35 billion by 2031.

What is the expected CAGR of the genotyping market?

The market is expected to register a CAGR of 22.5% during 2023–2031.

Which are the leading players operating in the genotyping market?

F. Hoffmann-La Roche Ltd, QIAGEN NV, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc, BioTek Instruments Inc, Xcelris, Trimgen Corporation, Illumina Inc, Danaher Corp, Bio-Rad Laboratories, HE Healthcare Technologies, Standard Biotools Inc, Laboratory Corp of America Holdings, Beckmann Coulter, BGI, Takara Bio, and Diasorin Spa are among the key players in the market.

The List of Companies - Genotyping Market

  1. F. Hoffmann-La Roche Ltd
  2. QIAGEN NV
  3. Merck KGaA
  4. Eurofins Genomics
  5. Thermo Fisher Scientific Inc
  6. BioTek Instruments Inc
  7. Xcelris
  8. Trimgen Corporation
  9. Illumina Inc
  10. Danaher Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..